Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
Jia‐Jia Wu, Zhenghong Lin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15056-15056
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 66
Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment
Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3474-3474
Open Access | Times Cited: 40
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
Epigenetic regulation in lung cancer
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 26
The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective
Samaneh Kahkesh, Seyedeh Mahdieh Khoshnazar, Yasaman Gholinezhad, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155316-155316
Closed Access | Times Cited: 12
Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
Jin Zhang, Yue Ma
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116909-116909
Open Access | Times Cited: 9
Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review
Juan Carlos Restrepo, Darly Martínez Guevara, Andrés Pareja López, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2338-2338
Open Access | Times Cited: 8
Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes
Yonglong Jin, Shosei Shimizu, Yinuo Li, et al.
Radiation Oncology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF‐1α signaling
Cailu Song, Qing Liu, Jing Qin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 7
Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm
Jing Zhang, Le Wu, Chenchen Wang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1385-1398
Open Access | Times Cited: 6
Drp1: Focus on Diseases Triggered by the Mitochondrial Pathway
Fulin Sun, Min Fang, Huhu Zhang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 435-455
Closed Access | Times Cited: 5
Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer
Wei Ye, Lu Xin, Yue Qiao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189108-189108
Closed Access | Times Cited: 5
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
13-Oxyingenol-dodecanoate inhibits the growth of non-small cell lung cancer cells by targeting ULK1
Xinye Wang, Yujue Wang, Bowen Guo, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107367-107367
Closed Access | Times Cited: 4
Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access
WDR62 mediates MAPK/ERK pathway to stimulate DNA damage repair and attenuate cisplatin sensitivity in lung adenocarcinoma
Li Xu, Yingwei Guo, Zecheng Qi, et al.
Anti-Cancer Drugs (2025)
Closed Access
Harnessing Pseudogenes for Lung Cancer: A Novel Epigenetic Target in Diagnosis, Prognosis and Treatment
Yock Young Dan, Xinyi Zhao, Jing Li, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104645-104645
Closed Access
Characterization and Identification of the Metabolites of Tuxobertinib in Rat, Dog, Monkey, and Human Liver Microsomes by Liquid Chromatography Combined With High Resolution Mass Spectrometry
Pei Liu, Jing Huang, Yao Zhao, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 3
Closed Access
Tumor‐Associated Macrophages: Key Players in the Non‐Small Cell Lung Cancer Tumor Microenvironment
Tongtong Lv, Rui Fan, Jiaqi Wu, et al.
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction
Ning Wang, Yinan Li, Yaoyao Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Deciphering the role of liquid-liquid phase separation in sarcoma: Implications for pathogenesis and treatment
Zehao Cheng, Hua Wang, Y M Zhang, et al.
Cancer Letters (2025) Vol. 616, pp. 217585-217585
Closed Access
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review
Hao Zhang, Wei Xia, Yifan Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Efficacy and Safety of Third-Generation EGFR-TKIs Combined with Radiotherapy for Advanced NSCLC with Typical EGFR Mutations: A Retrospective Study
Wenxuan Zhang, Haibo Xue, Zhao Ye, et al.
Current Medical Science (2025)
Closed Access
Network pharmacology and experimental analysis reveal Ethyl caffeate delays osimertinib resistance in lung cancer by suppression of MET
Shuliu Sang, Yang Han, Hailun Zhou, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top